Consistent with the results of the immune‐related prediction model for all ccRCC patients, patients with PBRM1 status data also showed that high‐risk patients tended to have poor prognosis compared to the low‐risk patients (Figure 6A). This evidence concerns the gene PBRM1 and nonpapillary renal cell carcinoma.